Major Injury Alters Brayden Schenn's Trade Status Ahead of Deadline
Photo credit: Jerome Miron-Imagn Images
A major health update from the St. Louis Blues is going to have a profound effect on what they do at the Trade Deadline, which falls tomorrow afternoon.
A major injury for the St. Louis Blues will almost certainly have a profound effect on what they choose to do by tomorrow's Trade Deadline.
It was announced by the team earlier today that defenseman
Colton Parayko won't play for the next six weeks after undergoing a scope in his knee following Wednesday's shootout win over the Los Angeles Kings.
St. Louis Blues President of Hockey Operations and General Manager Doug Armstrong announced today that defenseman Colton Parayko will undergo a scope on his left knee after injuring it during Wednesday's 3-2 shootout victory over the Los Angeles Kings.
Parayko will be re-evaluated in six weeks.
St. Louis' Trade Strategy Takes Dramatic Shift
Parayko, 31, has dressed in 62 games for the Blues this season, posting a career-best 15 goals and a career-high tying 35 points.
Among NHL defensemen overall, Parayko ranks 21st in points, fourth in goals, and 19th in ice-time per game (23:51).
The St. Albert, Alberta, native has appeared in 721 regular-season games across his 10-year career with the Blues, totaling 294 points (76 goals, 218 assists) and 198 penalty minutes.
He was originally drafted by the Blues in the third round, No. 86 overall, of the 2012 NHL Draft.
With GM Doug Armstrong not wanting to throw in the towel and trade Schenn, there's no doubt this injury throws not just a wrench, but the entire toolbox into his plans.
Without Parayko, the Blues are far, far worse, and it makes their job a far, far more difficult one if they want any chance of making the Stanley Cup Playoffs.